Dr. Hans Hammers is a distinguished professor in the Department of Internal Medicine at UT Southwestern Medical Center. He is also a co-leader for clinical research and immunotherapy in the Kidney Cancer Research Program, as well as the Experimental Therapeutics Program.
In this exclusive interview, Dr. Hammers provides insight into his journey as a leading expert in kidney cancer research and immunotherapy. He discusses the pivotal clinical trials he has led that have significantly impacted outcomes for patients with kidney cancer and shares his perspectives on the future of novel immunotherapies and targeted therapies.